12:00 AM
 | 
Dec 05, 2011
 |  BC Week In Review  |  Company News  |  Management Tracks

BioTime board of directors update

BioTime Inc. (NYSE-A:BTX), Alameda, Calif.
Business: Hematology, Gene/Cell...

Read the full 17 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >